BioCryst Pharmaceuticals Has Returned 15.1% Since SmarTrend Recommendation (BCRX)
November 12, 2015 at 10:23 AM EST
SmarTrend identified a Downtrend for BioCryst Pharmaceuticals (NASDAQ:BCRX) on September 28th, 2015 at $10.96. In approximately 2 month, BioCryst Pharmaceuticals has returned 15.05% as of today's recent price of...